INR 13.85
(-1.98%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - INR | 0.0% |
2022 | - INR | 0.0% |
2021 | - INR | 0.0% |
2020 | - INR | 0.0% |
2019 | - INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | 0.0% |
2015 | - INR | 0.0% |
2014 | - INR | -100.0% |
2013 | 2.3 Million INR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - INR | 0.0% |
2023 Q3 | - INR | 0.0% |
2023 Q4 | - INR | 0.0% |
2023 FY | - INR | 0.0% |
2023 Q1 | - INR | 0.0% |
2023 Q2 | - INR | 0.0% |
2022 Q3 | - INR | 0.0% |
2022 Q1 | - INR | 0.0% |
2022 Q2 | - INR | 0.0% |
2022 Q4 | - INR | 0.0% |
2021 Q1 | - INR | 0.0% |
2021 Q4 | - INR | 0.0% |
2021 Q3 | - INR | 0.0% |
2021 Q2 | - INR | 0.0% |
2020 Q1 | - INR | 0.0% |
2020 Q3 | - INR | 0.0% |
2020 Q2 | - INR | 0.0% |
2020 Q4 | - INR | 0.0% |
2019 Q2 | - INR | 0.0% |
2019 Q4 | - INR | 0.0% |
2019 Q3 | - INR | 0.0% |
2018 Q3 | - INR | 0.0% |
2018 Q4 | - INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2017 Q3 | - INR | 0.0% |
2017 Q2 | - INR | 0.0% |
2017 Q4 | - INR | 0.0% |
2017 Q1 | - INR | 0.0% |
2016 Q3 | - INR | 0.0% |
2016 Q2 | - INR | 0.0% |
2016 Q4 | - INR | 0.0% |
2016 Q1 | - INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 Q1 | - INR | 0.0% |
2015 Q3 | - INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 Q4 | - INR | 0.0% |
2013 Q4 | 2.3 Million INR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 14.13 Million INR | 100.0% |
Everest Organics Limited | 146.43 Million INR | 100.0% |
GUJARAT INJECT (KERALA) LTD. | - INR | NaN% |
NATURO INDIABULL LIMITED | 13.22 Million INR | 100.0% |
NEXUS SURGICAL AND MEDICARE LI | - INR | NaN% |
Rajnish Wellness Limited | 37.46 Million INR | 100.0% |
Rama Vision Limited | 56.61 Million INR | 100.0% |
Vivo Bio Tech Limited | 417.87 Million INR | 100.0% |